RxDoctor Payments Data

Megan Edwards, MD

Infectious Disease · Springfield, MANPI 1730446535

Payments from drug & device makers

$898in general payments, 2019–2025

Across 63 payments — averaging $14.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$556
  • Gilead$121
  • Cumberland Pharmaceuticals, Inc.$54
  • Medline Industries LP$29
  • AstraZeneca$27
  • AbbVie$25
  • plus $86 from 5 others

What the payments were for

  • Food & beverage$87698%
  • Education$222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$898 in reported general payments places this provider in the 65th percentile of 368 infectious disease providers in Massachusetts.

See all infectious disease providers in Massachusetts

Medicare billing

Part B allowed, 2024
$5,654
Medicare patients
72
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →